Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Early, Pre-Seed, Seed, Series A, Series B |
Investing | United States • United Kingdom • Europe |
Investment Range | $25,000 - $5,000,000 |
Investment Sweet Spot | $1,000,000 |
Advent Life Sciences is a venture capital firm which invests in early and mid-stage life sciences companies. In particular, it invests into new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines sectors. The firm was founded in 2010 and is based in London, United Kingdom.